围脂肪组织和高血压:观察和遗传分析
Hang Shen1, Zhipeng Wu1, Wenjin Luo1
1Department of Endocrinology, Sichuan-Chongqing Joint Key Laboratory of Metabolic Vascular Diseases, Chongqing Key Laboratory of Translational Medicine in Major Metabolic Diseases, The First Affiliated Hospital of Chongqing Medical University, China (H.S., Z. Wu, W.L., X.C., Q.Z., C.H., L.M., Z. Wang, Q.L., S.Y., J.H.).
Hypertension (Dallas, Tex. : 1979)
|July 29, 2025
概括
增加周周脂肪组织 (PRAT) 厚度与更高的高血压风险有关. 普拉特因果关系与异常性高阿尔多斯特隆症有关,而不是基本高血压.
科学领域:
- 心血管研究研究心血管研究
- 内分泌学 在内分泌学.
- 脂肪组织生物学 脂肪组织生物学
背景情况:
- 周周脂肪组织 (PRAT) 含有脂肪细胞,并影响血压.
- 了解PRAT在高血压中的作用对于心血管健康至关重要.
研究的目的:
- 调查PRAT厚度与整体和特异性高血压类型风险之间的关联.
- 使用遗传数据探索PRAT和高血压之间的潜在因果关系.
主要方法:
- 在英国生物库和CONPASS队列中测量的PRAT厚度.
- 对PRAT厚度和高血压发病率/几率的前性和横截面分析.
- 使用GWAS数据评估因果关系的双样本孟德尔随机化.
主要成果:
- 在英国生物库中,较高的PRAT厚度 (≥46.1毫米) 与高血压风险增加相关.
- 在CONPASS中,增加PRAT厚度与较高的低氨酸基本高血压和异常性过高阿尔多斯特的几率有关.
- PRAT厚度显示与异常性高血的因果关系,而不是其他形式的高血压.
结论:
- PRAT 厚度是高血压的重要危险因素,特别是异常性高阿尔多斯特隆症.
- 普拉特在异形性阿尔多多斯特隆症中起因作用,使其与基本高血压区别开来.
相关概念视频
01:21External Anatomy of the Kidney
1.6K
The kidneys are a pair of bean-shaped organs in the human body that play a critical role in maintaining overall health. They filter out waste products from the blood, regulate blood pressure, maintain electrolyte balance, and stimulate the production of red blood cells.
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
The kidneys are located in the retroperitoneal space on either side of the vertebral column, protected posteriorly by the 11th and 12th ribs. The right kidney sits slightly lower than the left owing to the presence of the liver...
1.6K
01:18Hypertension and Regulation of Blood Pressure
3.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
01:29Hypertension II: Pathophysiology
79
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
79
01:33Hormonal Regulation
33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
888
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
888
01:30Hypertension III: Clinical Manifestations and Diagnostic Studies
48
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48